PF-Atlas › Clinical Trials › NCT00875082

Effect of Montelukast on Remodelling Markers in Asthmatic Children

Montelukast · Phase 4

Registry ID

NCT00875082

Phase

Phase 4

Status

Completed

Drug / intervention

Montelukast

Sponsor

Universita di Verona

Start

2010-02

About this trial

Montelukast is evaluated in NCT00875082, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Universita di Verona. Current status: Completed.

View NCT00875082 on ClinicalTrials.gov →

Explore related

All Montelukast trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00875082 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.